Virax Biolabs Group Ltd - Class A (VRAX) Stock Price

2.86 ▲ +0.04 (+1.42%)
Open: 2.8486 Vol: 50.71K Day's range: 2.78 - 2.89 Aug 14, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
VRAX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL NEUTRAL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.82▲ 2.84▲ 2.84▲ 2.84▲ 3.09▼
MA10 2.85▲ 2.86▲ 2.86▲ 2.88▼ 2.61▲
MA20 2.87▼ 2.89▼ 2.89▼ 3.05▼ 1.39▲
MA50 3.02▼ 3.23▼ 3.27▼ 2.35▲ 0.80▲
MA100 3.42▼ 3.59▼ 3.76▼ 1.26▲ 1.12▲
MA200 3.71▼ 3.17▼ 2.30▲ 0.80▲ 2.65▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.011▲ 0.020▲ 0.024▲ -0.086▼ 0.201▲
RSI 45.395▼ 43.127▼ 41.873▼ 50.008▲ 65.820▲
STOCH 23.611     31.250     31.250     54.218     23.997    
WILL %R -62.500     -62.500     -62.500     -43.724     -79.017▼
CCI 4.179     -11.111     -18.667     -16.222     29.815    
Latest Filters Detected On VRAX
▲ RSI&VOL $VRAX RSI Cross Up and Volume Set Alert
RSI $VRAX RSI(14) Crossed Above 50 Set Alert
MA $VRAX Price Crossed Above MA(13) Set Alert
MA $VRAX Price Crossed Above MA(7) Set Alert
CDL $VRAX Doji Candlestick Pattern Detected Set Alert
Virax Biolabs Group Ltd - Class A News
Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Friday, August 07, 2026 12:00 PM
ORLANDO, FL / ACCESS Newswire / August 7, 2026 / RedChip Companies will air interviews with Virax Biolabs Group Ltd.
Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report
Saturday, July 18, 2026 01:50 AM
TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. RANK tracks the performance of the ...
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement
Thursday, July 16, 2026 04:30 AM
Preferred investment option exercise, completed July 10, 2026, generated approximately $3.3 million in gross proceeds, further strengthening the Company's liquidity position and balance sheet Nasdaq ...
VRAX historical stock data
date open high low close volume
14/08/26 2.8486 2.89 2.78 2.86 50,708
13/08/26 2.76 2.86 2.71 2.82 30,160
12/08/26 2.89 2.89 2.77 2.78 36,594
11/08/26 2.8302 2.91 2.83 2.87 18,140
10/08/26 2.99 2.99 2.79 2.88 34,451
07/08/26 2.795 2.9814 2.71 2.98 61,228
06/08/26 2.76 2.9067 2.74 2.77 76,355
05/08/26 3.10 3.10 2.84 2.91 44,042
04/08/26 2.84 3.07 2.84 2.98 133,101
03/08/26 2.62 2.94 2.5511 2.94 75,905
Quote Details
52wk Low:0.10
52wk High:13.17
Vol:50.71K
Avg Vol(3m):45.2M
1Y Chng:+400.79%
1M Chng:-8.04%
Add to Watch List
More Information
Index US Composite
Market Cap. 2.28M